ANGPTL3 and homozygous familial hypercholesterolemia: There are numerous other treatments in development for severe HeFH and HoFH, including inhibitors of angiopoietin like 3 protein (ANGPTL3), long-acting inhibitors of proprotein convertase subtilisin/kexin type 9 (PCSK9) in addition to gene therapies (59).